The Center for Pharmacoepidemiology and Treatment Sciences
Facilitating innovative science related to the use and outcomes of therapeutics and diagnostics in large populations.
Overview
The Center for Pharmacoepidemiology and Treatment Science, founded by Dr. Tobias Gerhard, and currently led by Dr. Vincent Lo Re, seeks to advance pharmacoepidemiology and related fields through world-class research and training. PETS is uniquely positioned to take advantage of the opportunities created by the breadth and scale of Rutgers Health.
In the News
“I’m honored to have been selected as director of PETS, and I’m excited about the center’s highly collaborative and impactful future. I look forward to working with schools and departments across Rutgers to recruit stellar faculty capable of conducting a broad range of rigorous research and enhancing the center’s productivity by developing innovative approaches to leveraging healthcare data.”
Vincent Lo Re III, M.D., M.S.C.E.
Our Research
PETS faculty are experienced pharmacoepidemiologists with training and a strong track-record in analyzing large clinical and administrative databases to study the utilization, safety, and comparative effectiveness/safety of drugs and devices and to develop new methods for studying treatment effects in large populations. Methodologic studies performed by faculty have focused on outcome validation, data linkage, approaches for dealing with confounding and bias (e.g., propensity scores, disease risk scores, instrumental variables, marginal structural models), and healthy user and healthy candidate bias. The PETS program is, by design and structure, interdisciplinary and committed not to any particular content area but rather to all relevant disciplines involving questions on the use and outcomes of therapeutics and diagnostics in large populations. The content interests of faculty members currently include cardiovascular medicine and heart failure, climate, schizophrenia, depression, and other mental disorders, juvenile idiopathic arthritis and other chronic inflammatory diseases. The areas of interest of adjunct PETS faculty from academia and industry are even more wide-ranging.
Our Training
PETS faculty are actively involved in educational efforts both locally and globally. At Rutgers, PETS faculty teach master’s and PhD students in pharmacoepidemiology methods as well as mentor undergraduates, graduate students, and clinical trainees in pharmacoepidemiologic research. PETS is working with the Rutgers School of Public Health to develop a certificate program and PhD program focused on pharmacoepidemiology and treatment science.
PETS faculty are also actively involved in the International Society for Pharmacoepidemiology (ISPE), serving in roles on the Education Committee and participating as faculty in a variety of courses at the annual International Conference on Pharmacoepidemiology & Therapeutic Risk Management.
Our Service
PETS faculty serve in a variety of positions locally, nationally, and globally to advance the health of individuals, communities, and populations. At Rutgers, PETS faculty are also faculty members at Rutgers Robert Wood Johnson Medical School, the Rutgers School of Pharmacy, and the Rutgers School of Public Health. Faculty members are involved in inpatient and outpatient patient care within the Departments of Internal Medicine and Pediatrics in Rutgers Health.
PETS faculty members serve on FDA Advisory Committees, on study sections at the National Institutes of Health, committees at the National Academies of Science, Engineering, and Medicine, and in various roles within clinical and research organizations, including the Childhood Arthritis and Rheumatology Research Alliance and the International Society for Pharmacoepidemiology (ISPE). They also participate in planning committees for the annual International Conference on Pharmacoepidemiology & Therapeutic Risk Management, organizing committee for the annual Asian Pharmacoepidemiology Conference, and on the editorial board for the Pharmacoepidemiology and Drug Safety journal.
Core Members
Vincent Lo Re, MD, MSCE, FISPE
Benjamin Bates, MD
Greta Bushnell, PhD
Chintan Dave, PharmD, PhD
Monica D’Arcy, PhD, MS
Tobias Gerhard, BSPharm, PhD, FISPE
Daniel B. Horton, MD, MSCE, FISPE
Farzin Khosrow-Khavar, PhD
Pia M. Mauro, PhD
Yola Moride, PhD, FISPE
Mary Beth Ritchey, PhD
Hillary Samples, PhD, MHS
Soko Setoguchi, MD, DrPH
Brian L. Strom, M.D., M.P.H.
Elizabeth A. Suarez, PhD, MPH
Adjunct Members
Jesse Berlin, ScD
Stephen Crystal, PhD, MA
Christopher Rowan, PhD
Jenny Sun, PhD
Sandra Lopez Leon, MD, PhD
Maribel Salas, MD, DSc, MSc, FACP, FISPE
Jason Roy, PhD
Research Staff
Haoqian Chen, PhD
Matthew Iozzio, MBA, MPP
Abner Nyandege, PhD
Dean M. Carbonari, MS
Kristen Lloyd, MPH
Sanika Rege, PhD, MS
Kim O’Malley, MS, PMP
Christine Jurcsek
Yuyang Zhu
Trainees
Julia Liaw, PharmD
Orges Alabaku, PhD
Jiaxun Zhao, MPH
Naomi Cruz
Ziyan Hong, MPH
Mackenzie Henderson, PharmD, MS
Robby Perna, MPH
Mireia Triguero Roura, PhD
Amina Alkhalaf, PharmD, MS
Hongjie (Harry) Qian, MS, BScPharm
Contact Us
![](https://ifh.rutgers.edu/wp-content/uploads/2025/02/RHIHHCPAR_H_WHITE.png")